Designing novel biologic agents to target colorectal cancer

Comments Off on Designing novel biologic agents to target colorectal cancer
New biologic drugs, such as monoclonal antibodies and immunotherapies in clinical development, designed to target metastatic colorectal cancer (CRC) and stimulate the immune system to destroy tumor cells are a significant advance in treatment over conventional chemotherapy.

mindsculptme

Related Posts

Create Account



Log In Your Account